DexCom (DXCM)
(Delayed Data from NSDQ)
$112.13 USD
+0.48 (0.43%)
Updated Jul 23, 2024 04:00 PM ET
After-Market: $112.47 +0.34 (0.30%) 7:58 PM ET
4-Sell of 5 4
D Value A Growth B Momentum C VGM
Brokerage Reports
0 items in cart
DexCom, Inc. [DXCM]
Reports for Purchase
Showing records 141 - 160 ( 414 total )
Company: DexCom, Inc.
Industry: Medical - Instruments
Potential Delay in FreeStyle Libre Consumer a Positive for DXCM
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
Medical Devices - Healthcare Conference
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
Company: DexCom, Inc.
Industry: Medical - Instruments
Company: DexCom, Inc.
Industry: Medical - Instruments
Healthy Results Despite Competitor Overhangs; Long-term Outlook Remains Robust
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
2Q17 Earnings Preview: Positive Underlying Dynamics
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
Company: DexCom, Inc.
Industry: Medical - Instruments
Company: DexCom, Inc.
Industry: Medical - Instruments
Diabetes Technology Insights from the ADA
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
Initial End-User Feedback on 670G System Somewhat Mixed, But A Step In The Right Direction
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
Company: DexCom, Inc.
Industry: Medical - Instruments
Mixed Start to the Year, But Trends Should Improve; Maintain OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
Discontinuation of Research Coverage
Provider: Feltl & Company
Company: DexCom, Inc.
Industry: Medical - Instruments
1Q17 Preview: Outperforming in MedTech Year-to-Date Reflects Stable Fundamentals That Should Continue Throughout 2017
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
Company: DexCom, Inc.
Industry: Medical - Instruments
Company: DexCom, Inc.
Industry: Medical - Instruments
Q4 inline, guidance maintained ? is more sales and support enough? Maintain SELL
Provider: Feltl & Company
Analyst: HAYNOR B
Company: DexCom, Inc.
Industry: Medical - Instruments
No Change in Outlook Just Yet; Maintain OUTPERFORM
Provider: WEDBUSH SECURITIES INC.